Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Cancer Metastatic × Patient Reported Outcome Measures × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasms 3 Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphoproliferative Disorders 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leukemia 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Esophageal Neoplasms 2 Bone Marrow Diseases 2 Sarcoma 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms, Second Primary 1 Myeloproliferative Disorders 1 Mobility Limitation 1

Interventions

Fulvestrant 3 Letrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 sacituzumab govitecan 1 ribociclib 1 pegfilgrastim 1 irinotecan sucrosofate 1 exemestane 1 abemaciclib 1 Zoledronic Acid 1 Tamoxifen 1 Paclitaxel 1 Neoadjuvant Therapy 1 Liposomes 1 Irinotecan 1 Gemcitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡